CIMAZ, ROLANDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 28.837
EU - Europa 14.419
AS - Asia 11.461
SA - Sud America 1.785
AF - Africa 437
OC - Oceania 280
Continente sconosciuto - Info sul continente non disponibili 5
Totale 57.224
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 28.551
RU - Federazione Russa 5.976
SG - Singapore 3.494
CN - Cina 2.152
HK - Hong Kong 1.868
IE - Irlanda 1.678
PL - Polonia 1.587
BR - Brasile 1.452
VN - Vietnam 1.381
SE - Svezia 1.357
IT - Italia 1.351
KR - Corea 1.083
FR - Francia 617
FI - Finlandia 572
DE - Germania 432
IN - India 340
GB - Regno Unito 334
TR - Turchia 288
AU - Australia 278
UA - Ucraina 177
JP - Giappone 169
CA - Canada 140
AR - Argentina 133
JO - Giordania 131
CI - Costa d'Avorio 128
ES - Italia 107
BD - Bangladesh 93
ID - Indonesia 91
IQ - Iraq 90
MX - Messico 79
NG - Nigeria 68
ZA - Sudafrica 64
CH - Svizzera 55
EC - Ecuador 54
NL - Olanda 52
PK - Pakistan 38
MA - Marocco 37
VE - Venezuela 34
EG - Egitto 31
SA - Arabia Saudita 29
CO - Colombia 27
CL - Cile 26
AZ - Azerbaigian 24
PH - Filippine 23
UZ - Uzbekistan 22
AT - Austria 21
PY - Paraguay 19
TN - Tunisia 19
BE - Belgio 17
SC - Seychelles 17
KE - Kenya 16
JM - Giamaica 15
TH - Thailandia 15
BO - Bolivia 14
AE - Emirati Arabi Uniti 13
DZ - Algeria 13
PE - Perù 13
IR - Iran 12
KZ - Kazakistan 12
LT - Lituania 12
UY - Uruguay 12
DO - Repubblica Dominicana 11
BG - Bulgaria 10
MY - Malesia 10
OM - Oman 10
MU - Mauritius 9
RO - Romania 9
TW - Taiwan 9
BH - Bahrain 8
CZ - Repubblica Ceca 8
HN - Honduras 8
CR - Costa Rica 7
IL - Israele 7
NP - Nepal 7
AL - Albania 6
ET - Etiopia 6
GT - Guatemala 6
LB - Libano 6
PT - Portogallo 6
SN - Senegal 6
BJ - Benin 5
KH - Cambogia 5
LV - Lettonia 5
PS - Palestinian Territory 5
RS - Serbia 5
BN - Brunei Darussalam 4
HU - Ungheria 4
KG - Kirghizistan 4
NO - Norvegia 4
PA - Panama 4
AO - Angola 3
BY - Bielorussia 3
CG - Congo 3
CM - Camerun 3
GA - Gabon 3
MM - Myanmar 3
NI - Nicaragua 3
QA - Qatar 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
Totale 57.177
Salva come PNG Salva come JPEG
Città #
Santa Clara 4.275
Fairfield 3.160
Ashburn 2.895
Singapore 2.422
Chandler 1.690
Dublin 1.675
Warsaw 1.582
Hong Kong 1.431
Woodbridge 1.390
Cambridge 1.300
Seattle 1.269
Houston 1.127
Seoul 1.072
Wilmington 1.031
Altamura 787
Lawrence 721
Beijing 658
Princeton 645
San Jose 635
The Dalles 479
Ann Arbor 450
Ho Chi Minh City 432
Lauterbourg 417
Boston 405
Jacksonville 339
Los Angeles 336
Buffalo 334
Dallas 331
Hanoi 324
Melbourne 262
Moscow 251
Izmir 239
New York 218
Boardman 216
Medford 215
Mumbai 213
Clifton 210
San Diego 184
Tokyo 154
Abidjan 128
Hefei 120
Falls Church 112
Florence 111
Helsinki 101
São Paulo 100
Shanghai 98
Munich 93
Council Bluffs 89
London 87
Barcelona 80
Norwalk 80
Redondo Beach 79
Frankfurt am Main 67
Toronto 65
Abuja 64
Paris 62
Da Nang 60
Guangzhou 60
Haiphong 60
Bern 52
Turku 50
Hillsboro 49
Jakarta 45
Yubileyny 45
Andover 43
Kent 42
Orem 42
Tianjin 40
Chicago 39
Dong Ket 38
Rio de Janeiro 38
Milan 37
Pune 36
Belo Horizonte 35
Baghdad 31
Curitiba 29
Johannesburg 29
Montreal 29
Brasília 28
Amman 27
Brooklyn 27
Philadelphia 27
Columbus 24
Phoenix 24
Denver 23
Porto Alegre 23
Chennai 21
Guayaquil 21
Quito 21
Shenzhen 21
Tashkent 21
Atlanta 20
Cairo 20
Dhaka 20
Rome 20
Thái Bình 20
Vienna 20
Baku 19
Can Tho 19
Campinas 18
Totale 38.723
Salva come PNG Salva come JPEG
Nome #
Chitinase 3-like-1 is produced by human Th17 cells and correlates with the level of inflammation in juvenile idiopathic arthritis patients 349
Expert consensus on dynamics of laboratory tests for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis 304
Th1-induced CD106 expression mediates leukocytes adhesion on synovial fibroblasts from juvenile idiopathic arthritis patients 298
First report of circulating microRNAs in tumour necrosis factor receptor-associated periodic syndrome (TRAPS). 293
Alteration of Fecal Microbiota Profiles in Juvenile Idiopathic Arthritis. Associations with HLA-B27 Allele and Disease Status. 291
The intestinal microbiota in enthesitis-related arthitis 270
Managing pediatric osteoporosis 266
Common symptoms for a rare disease in a girl with sarcoidosis: a case report 256
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study. 253
Disease status, reasons for discontinuation and adverse events in 1038 Italian children with juvenile idiopathic arthritis treated with etanercept 250
Distinctive features of classic and non-classic (Th17-derived) human Th1 cells. 245
Neonatal lupus: clinical features and risk of congenital cardiac heart block in newborns from mothers with anti Ro/SSA antibodies 243
Methotrexate in juvenile idiopathic arthritis: advice and recommendations from the MARAJIA expert consensus meeting 243
Rarity of human T helper 17 cells is due to retinoic acid orphan receptor-dependent mechanisms that limit their expansion. 234
Anti-adalimumab antibodies in a cohort of patients with juvenile idiopathic arthritis: incidence and clinical correlations 234
T cell subpopulations in juvenile idiopathic arthritis and their modifications after biotherapies 228
Disease activity assessment in childhood vasculitis: development and preliminary validation of the Paediatric Vasculitis Activity Score (PVAS). 225
Anti-inflammatory and immunosuppressive drugs and reproduction. 225
Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic modifier drug: Adalimumab as starting anti-TNF-alpha therapy in childhood chronic uveitis. 225
Elicitation of expert prior opinion: application to the MYPAN trial in childhood polyarteritis nodosa 220
Immunosuppressive Activity of Abatacept on Circulating T Helper Lymphocytes from Juvenile Idiopathic Arthritis Patients 217
Does switching anti-TNFα biologic agents represent an effective option in childhood chronic uveitis: The evidence from a systematic review and meta-analysis approach. 213
Musculin inhibits human T helper 17 cell response to interleukin 2 by controlling STAT5B activity 209
Identification of autoantibodies against inner ear antigens in a cohort of children with idiopathic sensorineural hearing loss. 205
Bone status of children born from mothers with autoimmune diseases treated during pregnancy with prednisone and/or low molecular weight heparin. 202
Congenital heart block and immune mediated sensorineural hearing loss: possible cross reactivity of immune response 200
Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis. 199
Mycophenolate mofetil as induction and long-term maintaining treatment in childhood: Primary angiitis of the central nervous system 197
Demethylation of the RORC2 and IL17A in Human CD4+ T Lymphocytes Defines Th17 Origin of Nonclassic Th1 Cells. 196
Detection of anti-adalimumab antibodies in a RA responsive cohort of patients using three different techniques 196
Anticorpi anti-istone: È sempre lupus indotto da farmaci? 195
Overexpression of the transmembrane carbonic anhydrase isoforms IX and XII in the inflamed synovium 195
Kawasaki disease: an epidemiological study in central Italy 194
Extracoronary echocardiographic findings as predictors of coronary artery lesions in the initial phase of Kawasaki disease. 194
Describing Kawasaki shock syndrome: results from a retrospective study and literature review 194
Safety and efficacy of infliximab and adalimumab for refractory uveitis in juvenile idiopathic arthritis: 1-year followup data from the Italian Registry. 193
Difficult-To-Treat Juvenile Idiopathic Arthritis: Current and Future Options 185
Kawasaki disease in Sicily: clinical description and markers of disease severity. 185
The expanding spectrum of low-penetrance TNFRSF1A gene variants in adults presenting with recurrent inflammatory attacks: Clinical manifestations and long-term follow-up. 185
Eomes controls the development of Th17-derived (non-classic) Th1 cells during chronic inflammation 185
Surface plasmon resonance-based methodology for anti-adalimumab antibody identification and kinetic characterization 184
Clinical and transcriptional response to the long-acting interleukin-1 blocker canakinumab in Blau syndrome-related uveitis. 182
Atypical presentation of anti-N-methyl-D-aspartate receptor encephalitis: Two case reports 182
Methotrexate in juvenile chronic arthritis. 181
Correction to: The Italian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 180
Idiopathic congenital atrophoderma of Pasini and Pierini 180
Psoriatic juvenile idiopathic arthritis associated with uveitis: a case report. 179
Health related quality of life measure in systemic pediatric rheumatic diseases and its translation to different languages: An international collaboration 177
Clues to detect tumor necrosis factor receptor-associated periodic syndrome (TRAPS) among patients with idiopathic recurrent acute pericarditis: results of a multicentre study. 177
Kawasaki disease in infants less than one year of age: An Italian cohort from a single center 176
Evidence of the transient nature of the Th17 phenotype of CD4+CD161+ T cells in the synovial fluid of patients with juvenile idiopathic arthritis. 174
Common variable immunodeficiency presenting as sarcoidosis in a 9-year-old child 174
Comparing ultraviolet light A photo(chemo)therapy with Methotrexate protocol in childhood localized scleroderma: Evidence from systematic review and meta-analysis approach 173
Lack of association between the HLA-DRB1 locus and post-streptococcal reactive arthritis and acute rheumatic fever in italian children 172
Pediatric Osteoporosis: Diagnosis and Treatment Considerations 172
Inflammatory morphea presenting as a hemifacial acquired port-wine stain 172
Development and Initial Validation of the Macrophage Activation Syndrome/Primary Hemophagocytic Lymphohistiocytosis Score, a Diagnostic Tool that Differentiates Primary Hemophagocytic Lymphohistiocytosis from Macrophage Activation Syndrome 172
Clonally expanded PD-1-expressing T cells are enriched in synovial fluid of juvenile idiopathic arthritis patients 171
Joint pain management in children and adolescents 170
A 10-year follow-up of alendronate-treated young patients 170
Treating juvenile idiopathic arthritis to target: recommendations of an international task force 169
Epidemiology of Kawasaki disease in Italy: surveillance from national hospitalization records 168
The Italian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 168
Systemic Lupus Erythematosus and Bullous Pemphigoid with Dramatic Response to Dapsone 167
Anakinra treatment in drug-resistant Behcet's disease: a case series. 167
Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis 165
Th17 and Th1 lymphocytes in oligoarticular juvenile idiopathic arthritis 165
Bone mass predictors in a large cohort of children with juvenile idiopathic arthritis (JIA) 164
Association of low bone mass with vitamin d receptor gene and calcitonin receptor gene polymorphisms in juvenile idiopathic arthritis. 163
Clinical features and outcome of Cogan syndrome. 161
Partial Rescue of Biochemical Parameters After Hematopoietic Stem Cell Transplantation in a Patient with Prolidase Deficiency Due to Two Novel PEPD Mutations. 160
Anti-TNF agents for the treatment of JIA-related Refractory Uveitis: 2010 UPDATE from the Italian Registry 160
Mucopolysaccharidoses. 159
Flares after withdrawal of biologic therapies in juvenile idiopathic arthritis: Clinical and laboratory correlates of remission duration 159
Recurrent Pericarditis In Children and Adolescents: Etiology, Presentation, Therapies, and Outcomes In a Multicenter Retrospective Cohort Of 100 Patients. 158
Canakinumab for the treatment of TNF-receptor associated periodic syndrome 158
Evidence of a Transient Nature of the th17 Phenotype of cd4+cd161+t Cells in the Synovial Fluid From Patients with Juvenile Idiopathic Arthritis 157
AB1025 Chronic Recurrent Multifocal Osteomyelitis (CRMO): The Importance of an Accurate Differential Diagnosis 155
How advances in personalized medicine will change rheumatology 155
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study 154
Current evidence of methotrexate efficacy in childhood chronic uveitis: a systematic review and meta-analysis approach. 153
Childhood uveitis 153
Glucocorticoids in the management of systemic juvenile idiopathic arthritis. 153
Successful treatment with canakinumab of a paediatric patient with resistant Behçet's disease 153
Predictors of Relapse after Discontinuing Systemic Treatment in Childhood Autoimmune Chronic Uveitis 152
A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial). 152
Sex Differences in Pediatric Rheumatology 151
Clinical Features at Onset and Genetic Characterization of Pediatric and Adult Patients with TNF- α Receptor - Associated Periodic Syndrome (TRAPS): A Series of 80 Cases from the AIDA Network 151
Biological treatments in behçet's disease: Beyond anti-TNF therapy 151
Idiopathic calcinosis in a paediatric patient 150
Bone status evaluation with calcaneal ultrasound in children with chronic rheumatic diseases. A one year followup study. 150
The diagnostic evaluation of patients with potential adult-onset autoinflammatory disorders: Our experience and review of the literature. 150
CD4+CD161+cells with Th1 or Th17/Th1 profile accumulate in the synovial fluid of patients with oligo- and polyarticular juvenile idiopathic arthritis 149
2016 ACR-EULAR adult dermatomyositis and polymyositis and juvenile dermatomyositis response criteria-methodological aspects 149
Antigen-driven PD-1+TOX+BHLHE40+ and PD-1+TOX+EOMES+ T lymphocytes regulate juvenile idiopathic arthritis in situ 149
How I treat juvenile idiopathic arthritis: A state of the art review 148
A boy with bizarre hands mimicking an inflammatory chronic disease. 148
Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease. 148
Development and Implementation of the AIDA International Registry for Patients with Non-Infectious Uveitis 148
Clinical and Therapeutic Features of 312 Patients with Macrophage Activation Syndrome Enrolled in a Multinational Survey 147
Totale 18.846
Salva come PNG Salva come JPEG
Categoria #
all - tutte 172.312
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 172.312
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021538 0 0 0 0 0 0 0 0 0 0 250 288
2021/20223.007 115 333 234 160 87 129 92 254 151 89 327 1.036
2022/20237.742 955 1.820 258 524 539 1.439 846 351 587 33 257 133
2023/20242.103 101 342 515 132 129 323 63 287 42 59 69 41
2024/202514.892 727 1.837 1.097 2.369 4.172 1.356 246 803 1.050 388 470 377
2025/202615.332 1.634 2.514 1.156 1.366 1.836 811 2.454 1.070 1.176 987 328 0
Totale 57.831